Cargando…

Oral Ketamine in Treatment-Resistant Depression: A Clinical Effectiveness Case Series

PURPOSE: The aim of the study was to assess the effectiveness, tolerability, and safety of oral ketamine as an antidepressant treatment in adults with treatment-resistant depression. METHODS: We reviewed retrospective data on 22 patients with treatment-resistant depression, who failed at least 3 ade...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al Shirawi, Maryam I., Kennedy, Sidney H., Ho, Keith T., Byrne, Roisin, Downar, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2017
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491240/ https://www.ncbi.nlm.nih.gov/pubmed/28514237 http://dx.doi.org/10.1097/JCP.0000000000000717

Ejemplares similares

A Pilot Study Investigating the Effect of Music-Based Intervention on Depression and Anhedonia
por: Braun Janzen, Thenille, et al.
Publicado: (2019)

Somatic Comorbidities and Cardiovascular Safety in Ketamine Use for Treatment-Resistant Depression
por: Szarmach, Joanna, et al.
Publicado: (2021)

Investigating the Effects of Auditory and Vibrotactile Rhythmic Sensory Stimulation on Depression: An EEG Pilot Study
por: Mosabbir, Abdullah A, et al.
Publicado: (2022)

Clinical Efficacy of Ketamine for Treatment-resistant Depression
por: Bratsos, Sosipatros, et al.
Publicado: (2019)

Oral ketamine for phantom limb pain: An option for challenging cases
por: Mitra, Sukanya, et al.
Publicado: (2015)

Accelerated Intermittent Theta Burst Stimulation in Late-Life Depression: A Possible Option for Older Depressed Adults in Need of ECT During the COVID-19 Pandemic
por: Konstantinou, Gerasimos N., et al.
Publicado: (2020)

The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression
por: Hashimoto, Kenji
Publicado: (2014)

Esketamine/ketamine for treatment-resistant depression
por: Lacerda, Acioly L.T.
Publicado: (2020)

Magnesium in Ketamine Administration in Treatment-Resistant Depression
por: Górska, Natalia, et al.
Publicado: (2021)

Case Report: Repeated Series of Ketamine Infusions in Patients With Treatment-Resistant Depression: Presentation of Five Cases
por: Gałuszko-Wȩgielnik, Maria, et al.
Publicado: (2021)

Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression
por: McMullen, Eric P., et al.
Publicado: (2021)

Resting-State Cortico-Thalamic-Striatal Connectivity Predicts Response to Dorsomedial Prefrontal rTMS in Major Depressive Disorder
por: Salomons, Tim V, et al.
Publicado: (2014)

Rapid Antidepressant Response with Ketamine: Is it the Solution to Resistant Depression?
por: Thakurta, Rajarshi Guha, et al.
Publicado: (2012)

Rapid Response with Ketamine on Suicidal Cognition in Resistant Depression
por: Thakurta, Rajarshi Guha, et al.
Publicado: (2012)

Copper Concentrations in Ketamine Therapy for Treatment-Resistant Depression
por: Słupski, Jakub, et al.
Publicado: (2020)

Habenula Connectivity and Intravenous Ketamine in Treatment-Resistant Depression
por: Rivas-Grajales, Ana Maria, et al.
Publicado: (2020)

How effective are ketamine or esketamine in treatment-resistant depression?
por: Veluri, N., et al.
Publicado: (2021)

The Downstaging Concept in Treatment-Resistant Depression: Spotlight on Ketamine
por: Wilkowska, Alina, et al.
Publicado: (2022)

Ketamine as Add-On Treatment in Psychotic Treatment-Resistant Depression
por: Gałuszko-Węgielnik, Maria, et al.
Publicado: (2023)

Neural and Behavioral Correlates of Clinical Improvement to Ketamine in Adolescents With Treatment Resistant Depression
por: Thai, Michelle, et al.
Publicado: (2020)

Effects of intranasal (S)-ketamine on Veterans with co-morbid treatment-resistant depression and PTSD: A retrospective case series
por: Artin, Hewa, et al.
Publicado: (2022)

Oral S-ketamine effective after deep brain stimulation in severe treatment-resistant depression and extensive comorbidities
por: Veraart, Jolien K E, et al.
Publicado: (2021)

Hippocampal subfield volumes in treatment resistant depression and serial ketamine treatment
por: Zavaliangos-Petropulu, Artemis, et al.
Publicado: (2023)

Perspectives of Ketamine Use in COVID-19 Patients
por: Weinbroum, Avi A
Publicado: (2021)

Effects of ketamine treatment on suicidal ideation: a qualitative study of patients’ accounts following treatment for depression in a UK ketamine clinic
por: Lascelles, Karen, et al.
Publicado: (2019)

A longitudinal case series of IM ketamine for patients with severe and enduring eating disorders and comorbid treatment‐resistant depression
por: Schwartz, Terry, et al.
Publicado: (2021)

Sociodemographic Profile of Patients Visiting Ketamine Clinic For Treatment Resistant Depression And Active Suicidality.
Publicado: (2022)

The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review
por: Serafini, Gianluca, et al.
Publicado: (2014)

Oral ketamine may offer a solution to the ketamine conundrum
por: Dutton, Megan, et al.
Publicado: (2023)

Oral and Intranasal Ketamine Use in Treatment-Resistant Catatonia: A Clinical Case Report
por: Gregor, Elizabeth, et al.
Publicado: (2023)

Real-World, Multicenter Case Series of Patients Treated with Oral Omadacycline for Resistant Gram-Negative Pathogens
por: Morrisette, Taylor, et al.
Publicado: (2022)

S-Ketamine in the treatment of depressive emergencies: a cases series of patients in a suicidal crisis
por: Baune, B., et al.
Publicado: (2022)

PS101. Oral Ketamine for Treatment Resistant Major Depression – A double blind randomized controlled trial
por: Domany, Yoav, et al.
Publicado: (2016)

Ketamine treatment for individuals with treatment-resistant depression: longitudinal qualitative interview study of patient experiences
por: Lascelles, Karen, et al.
Publicado: (2020)

The Efficacy and Safety of Procedural Sedoanalgesia with Midazolam and Ketamine in Pediatric Hematology
por: Gelen, Sema Aylan, et al.
Publicado: (2015)

Fentanyl or ketamine pre-treatment to prevent withdrawal response to rocuronium
por: Kosare, Suchita S, et al.
Publicado: (2017)

A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol
por: Phillips, Jennifer L., et al.
Publicado: (2020)

A unique case of very low‐dose subcutaneous ketamine use: Maintenance option of ketamine for treatment‐resistant depression
por: Can, Adem T., et al.
Publicado: (2022)

Changes in white matter microstructure following serial ketamine infusions in treatment resistant depression
por: Taraku, Brandon, et al.
Publicado: (2023)

Ketamine-induced affective switch in a patient with treatment-resistant depression
por: Banwari, Girish, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lmqim2b0uvbc19df5rg8m5mtjj